There remains debate regarding the impact of cannabis on neuropsychiatric disorders.
Here, we examined the effects of cannabidiol (CBD), a nonpsychoactive constituent of …

Cannabis sativa is the most widely used illicit drug in the world. Its main psychoactive
component is delta‐9‐tetrahydrocannabinol (THC), one of over 100 phytocannabinoid …

Cannabinoid derivatives have shown promising results for treating neuropsychiatric
disorders, including drug addiction. Recent studies on the therapeutic effects of Cannabidiol …

Background Cannabis is the most widely used illicit drug, but knowledge of the neurological
consequences of cannabis use is deficient. Two primary components of cannabis are Δ 9 …

Background Cannabidiol (CBD) is one of the major constituents of Cannabis sativa L. that
lacks psychotomimetic and rewarding properties and inhibits the rewarding and reinforcing …

Increases in mesolimbic dopamine transmission are observed when animals are treated
with all known drugs of abuse, including cannabis, and to conditioned stimuli predicting their …

Currently, there are no approved pharmacotherapies for addiction to cocaine and other
psychostimulant drugs. Several studies have proposed that cannabidiol (CBD) could be a …

Recent trends in cannabis legalization have increased the necessity to better understand
the effects of cannabis use. Animal models involving traditional cannabinoid self …

Cannabis is the most widely used illicit drug worldwide. Regular cannabis use has been
associated with a range of acute and chronic mental health problems, such as anxiety …

Cocaine abuse continues to be a serious health problem worldwide. Despite intense
research there is currently no FDA-approved medication to treat cocaine use disorder. The …